CCPLUS
LIVE

Serial Number

77209909

Owner

SVAR Life Science AB

Attorney

Kevin A. Thompson

Filing Date

Jun 19, 2007

Add to watchlist:

No watchlists yet
View on USPTO

CCPLUS Trademark

Serial Number: 77209909 • Registration: 3906100

CCPLUS is a trademark filed by SVAR Life Science AB on June 19, 2007. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

SVAR Life Science AB (5 trademarks)

Box 50117

Entity Type: 09

Euro-Diagnostica AB (5 trademarks)

Medeon

Entity Type: 09

Trademark Details

Filing Date

June 19, 2007

Registration Date

January 18, 2011

Published for Opposition

November 2, 2010

Goods & Services

Diagnostic preparations for clinical or medical laboratory use; medical diagnostic reagents and assays for testing of bodily fluids; medical diagnostic reagents; diagnostic agents, preparations and substances for medical purposes; kits comprised principally of medical diagnostic assays for testing of bodily fluids; testing kits containing peptide substrates used in analyzing and detecting certain proteins indicating onset of human joint inflammatory disease, for clinical or laboratory use; in vitro diagnostic test kits for detection of rheumatoid arthritis comprised primarily of reagents for medical diagnostic use; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain antibodies to cyclic citrullinated peptides for clinical or medical laboratory use; testing kits containing peptide substrates used in analyzing and detecting certain antibodies to cyclic citrullinated peptides for clinical or medical laboratory use; medical diagnostic test kits for the detection of rheumatoid arthritis, principally comprised of microtitre peptide substrates and reagents; medical diagnostic test kits, featuring reagents and peptide coated receptacle substrates, for the detection of auto-immune joint disease; medical diagnostic enzyme linked immunoassay (ELISA) tests, comprised primarily of medical diagnostic preparations in the nature of bodily serum(a) holders such as microtitre plates with wells having areas coated with antigenic preparations(s) for detection of antibodies to cyclic citrullinated peptides (CCP), for clinical or laboratory use

[ Apparatus for clinical diagnosis; apparatus for blood analysis; blood testing apparatus ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jan 21, 2021 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jan 21, 2021 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jan 21, 2021 89AG
TEAS SECTION 8 & 9 RECEIVED
Jan 19, 2021 E89R
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 26, 2020 ASGN
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 18, 2020 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Mar 6, 2017 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Mar 6, 2017 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 6, 2017 APRE
TEAS SECTION 8 & 15 RECEIVED
Jan 3, 2017 E815
REGISTERED-PRINCIPAL REGISTER
Jan 18, 2011 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 2, 2010 NPUB
PUBLISHED FOR OPPOSITION
Nov 2, 2010 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 27, 2010 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 24, 2010 CNSA
DATA MODIFICATION COMPLETED
Sep 23, 2010 DMCC
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 7, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 7, 2010 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 6, 2010 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 6, 2010 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 6, 2010 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 6, 2010 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 9, 2010 RCCK
ASSIGNED TO LIE
Jul 9, 2010 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 5, 2010 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 5, 2010 GNSL
SUSPENSION LETTER WRITTEN
Jan 5, 2010 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 7, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 7, 2009 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 7, 2009 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jun 16, 2009 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jun 16, 2009 GNSI
SUSPENSION INQUIRY WRITTEN
Jun 16, 2009 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 26, 2009 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 26, 2008 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 26, 2008 GNSL
SUSPENSION LETTER WRITTEN
Nov 26, 2008 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 25, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 25, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 15, 2008 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 10, 2008 GNRN
NON-FINAL ACTION E-MAILED
Sep 10, 2008 GNRT
NON-FINAL ACTION WRITTEN
Sep 10, 2008 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 2, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 2, 2008 CRFA
ASSIGNED TO LIE
Aug 2, 2008 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 31, 2008 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 6, 2008 GNRN
NON-FINAL ACTION E-MAILED
Feb 6, 2008 GNRT
NON-FINAL ACTION WRITTEN
Feb 6, 2008 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 27, 2007 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 27, 2007 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 27, 2007 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 10, 2007 GNRN
NON-FINAL ACTION E-MAILED
Oct 10, 2007 GNRT
NON-FINAL ACTION WRITTEN
Oct 10, 2007 CNRT
ASSIGNED TO EXAMINER
Sep 21, 2007 DOCK
NEW APPLICATION ENTERED
Jun 22, 2007 NWAP